These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33951909)

  • 1. Utilizing Laser Activation of Photothermal Plasmonic Nanoparticles to Induce On-Demand Drug Amorphization inside a Tablet.
    Hempel NJ; Merkl P; Asad S; Knopp MM; Berthelsen R; Bergström CAS; Teleki A; Sotiriou GA; Löbmann K
    Mol Pharm; 2021 Jun; 18(6):2254-2262. PubMed ID: 33951909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperthermia-Induced In Situ Drug Amorphization by Superparamagnetic Nanoparticles in Oral Dosage Forms.
    Ansari SR; Hempel NJ; Asad S; Svedlindh P; Bergström CAS; Löbmann K; Teleki A
    ACS Appl Mater Interfaces; 2022 May; 14(19):21978-21988. PubMed ID: 35452221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of the Molecular Weight of Polyvinylpyrrolidone and the Model Drug on Laser-Induced In Situ Amorphization.
    Hempel NJ; Merkl P; Knopp MM; Berthelsen R; Teleki A; Hansen AK; Sotiriou GA; Löbmann K
    Molecules; 2021 Jul; 26(13):. PubMed ID: 34279377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Influence of Drug-Polymer Solubility on Laser-Induced In Situ Drug Amorphization Using Photothermal Plasmonic Nanoparticles.
    Hempel NJ; Merkl P; Knopp MM; Berthelsen R; Teleki A; Sotiriou GA; Löbmann K
    Pharmaceutics; 2021 Jun; 13(6):. PubMed ID: 34205754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amorphous Salts Solid Dispersions of Celecoxib: Enhanced Biopharmaceutical Performance and Physical Stability.
    Mukesh S; Joshi P; Bansal AK; Kashyap MC; Mandal SK; Sathe V; Sangamwar AT
    Mol Pharm; 2021 Jun; 18(6):2334-2348. PubMed ID: 34003656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of drug and polymer particle size on the in situ amorphization using microwave irradiation.
    Hempel NJ; Knopp MM; Berthelsen R; Zeitler JA; Löbmann K
    Eur J Pharm Biopharm; 2020 Apr; 149():77-84. PubMed ID: 32035238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Influence of Temperature and Viscosity of Polyethylene Glycol on the Rate of Microwave-Induced In Situ Amorphization of Celecoxib.
    Hempel NJ; Dao T; Knopp MM; Berthelsen R; Löbmann K
    Molecules; 2020 Dec; 26(1):. PubMed ID: 33383672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of microwave-induced amorphization of celecoxib in PVP tablets using transmission Raman spectroscopy.
    Edinger M; Knopp MM; Kerdoncuff H; Rantanen J; Rades T; Löbmann K
    Eur J Pharm Sci; 2018 May; 117():62-67. PubMed ID: 29428542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a multiparticulate drug delivery system for in situ amorphisation.
    Holm TP; Kokott M; Knopp MM; Boyd BJ; Berthelsen R; Quodbach J; Löbmann K
    Eur J Pharm Biopharm; 2022 Nov; 180():170-180. PubMed ID: 36191869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation into the role of the polymer in enhancing microwave-induced in situ amorphization.
    Qiang W; Löbmann K; Knopp MM; McCoy CP; Andrews GP; Zhao M
    Int J Pharm; 2021 Nov; 609():121157. PubMed ID: 34626795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study on mechanism for amorphous drug stabilization using gelucire 50/13.
    Shimpi SL; Mahadik KR; Paradkar AR
    Chem Pharm Bull (Tokyo); 2009 Sep; 57(9):937-42. PubMed ID: 19721253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amorphization within the tablet: Using microwave irradiation to form a glass solution in situ.
    Doreth M; Hussein MA; Priemel PA; Grohganz H; Holm R; Lopez de Diego H; Rades T; Löbmann K
    Int J Pharm; 2017 Mar; 519(1-2):343-351. PubMed ID: 28115260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microwave-Induced in Situ Drug Amorphization Using a Mixture of Polyethylene Glycol and Polyvinylpyrrolidone.
    Hempel NJ; Knopp MM; Zeitler JA; Berthelsen R; Löbmann K
    J Pharm Sci; 2021 Sep; 110(9):3221-3229. PubMed ID: 34022194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barrier coated drug layered particles for enhanced performance of amorphous solid dispersion dosage form.
    Puri V; Dantuluri AK; Bansal AK
    J Pharm Sci; 2012 Jan; 101(1):342-53. PubMed ID: 21935949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of drug-excipient interaction in the formulation of celecoxib tablets.
    Bozdağ-Pehlivan S; Subaşi B; Vural I; Unlü N; Capan Y
    Acta Pol Pharm; 2011; 68(3):423-33. PubMed ID: 21648198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.
    Agrawal A; Dudhedia M; Deng W; Shepard K; Zhong L; Povilaitis E; Zimny E
    AAPS PharmSciTech; 2016 Feb; 17(1):214-32. PubMed ID: 26757898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the capacity of low glass transition temperature excipients to minimize amorphization of sulfadimidine on comilling.
    Curtin V; Amharar Y; Hu Y; Erxleben A; McArdle P; Caron V; Tajber L; Corrigan OI; Healy AM
    Mol Pharm; 2013 Jan; 10(1):386-96. PubMed ID: 23186332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles.
    Liu Y; Sun C; Hao Y; Jiang T; Zheng L; Wang S
    J Pharm Pharm Sci; 2010; 13(4):589-606. PubMed ID: 21486533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Use of Glycerol as an Enabling Excipient for Microwave-Induced In Situ Drug Amorphization.
    Hempel NJ; Morsch F; Knopp MM; Berthelsen R; Löbmann K
    J Pharm Sci; 2021 Jan; 110(1):155-163. PubMed ID: 33058897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anomalous dissolution behavior of celecoxib in PVP/Isomalt solid dispersions prepared using spray drier.
    Ghanavati R; Taheri A; Homayouni A
    Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():501-511. PubMed ID: 28024614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.